Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

52 projects found matching your search criteria :

  1. Optymalizacja strategii proteomicznych w analizie materiału biologicznego w oparciu o technikę MALDI TOF/TOF MS

    Call: ETIUDA 3 , Panel: NZ7

    Principal investigator: Joanna Hajduk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  2. Proteasome activation as a strategy for attenuation of aging and neurodegenerative processes

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: dr hab. Elżbieta Jankowska

    Uniwersytet Gdański, Wydział Chemii

  3. Proteomic and metabolomic strategy of searching for biomarkers of genital cancer diseases using mass spectrometry method...

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: prof. Zenon Józef Kokot

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  4. Operational risk associated with the strategy implementation. Model approach.

    Call: SONATA 7 , Panel: HS4

    Principal investigator: dr Joanna Radomska

    Uniwersytet Ekonomiczny we Wrocławiu, Wydział Nauk Ekonomicznych

  5. The motor unit plasticity in the strenght training

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: prof. Jan Stefan Celichowski

    Akademia Wychowania Fizycznego im. Eugeniusza Piaseckiego w Poznaniu, Wydział Wychowania Fizycznego, Sportu i Rehabilitacji

  6. Relational resources of public companies in Poland in the perspective of network structural analysis

    Call: OPUS 6 , Panel: HS4

    Principal investigator: dr hab. Justyna Maria Światowiec-Szczepańska

    Uniwersytet Ekonomiczny w Poznaniu, Wydział Zarządzania

  7. Functionalization of photosensitizing compounds with antimicrobial peptides to enhance photoantimicrobial chemotherapy o...

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: dr Joanna Nakonieczna

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  8. DNA double-stranded break repair proteins as a target for personalized cancer therapy based on synthetic lethality

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  9. Biomedical analysis of alternative therapy of chronic wound infections. In vitro research with plant polyphenols.

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: Małgorzata Paszkiewicz

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  10. Prevalence of Chalmydia trachomatis infection among teenagers in Cracow and in Warsaw - pilot study to assess screening ...

    Call: OPUS 1 , Panel: NZ7

    Principal investigator: prof. Andrzej Tadeusz Zieliński

    Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

  11. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr Michał Andrzej Abram

    Uniwersytet Jagielloński

  12. Strategy to overcome the "ionic checkpoint" and improve the antitumor immunotherapy.

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr Beata Pyrzyńska

    Warszawski Uniwersytet Medyczny

  13. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr hab. Robert Czarnomysy

    Uniwersytet Medyczny w Białymstoku

  14. Decision-making under sources of uncertainty: strategic interaction, temporal delay, risk, ambiguity and indecisiveness

    Call: OPUS 29 , Panel: HS4

    Principal investigator: dr Michał Lewandowski

    Szkoła Główna Handlowa w Warszawie

  15. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Alicja Stanisława Słota

    Uniwersytet Jagielloński

  16. Disrupting the Toxic NMDAR/TRPM4 Protein Dialogue as a Novel Neuroprotective Strategy: Development of Small-Molecule Inh...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Katarzyna Aleksandra Szafrańska

    Uniwersytet Jagielloński

  17. A new strategy to fight antibiotic resistance based on hybrids of fluoroquinolones and quaternary ammonium salts

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Joanna Dagmara Fedorowicz

    Gdański Uniwersytet Medyczny

  18. Targeting Telomere Integrity as an Approach to Eradicate Cancer Cells

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Natalia Anna Maciejewska

    Politechnika Gdańska

  19. Defining The Role of Microbiome Mimicry in Type 1 Diabetes (T1D): a pilot study for Single-Cell Strain-characterisation ...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Marcin Lukasz Pekalski

    Wojskowy Instytut Medyczny

  20. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Monika Emilia Marcinkowska

    Uniwersytet Jagielloński

  21. Phage-Antimicrobial combination Strategies for management of multidrug-resistant E. coli and K. pneumoniae

    Call: JPIAMR ACTION Call 2024 , Panel: NZ7

    Principal investigator: prof. Krystyna Dąbrowska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  22. Modulation of the Gut Microbiome as a Strategy to Counteract Hormone-Dependent Disorders

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Janeczko

    Uniwersytet Przyrodniczy we Wrocławiu

  23. Metallacarborane-peptide amphiphiles as a new strategy in the fight against multidrug-resistant Gram-negative bacteria

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Krzysztof Konrad Fink

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  24. Determinants of the Polish enterprises' resilience to economic crisis

    Call: OPUS 2 , Panel: HS4

    Principal investigator: prof. Maria Hanna Romanowska

    Szkoła Główna Handlowa w Warszawie

  25. Effect of a short-term multi-strain probiotic supplementation on the exercise-associated gastrointestinal disturbances i...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Natalia Maria Główka

    Akademia Wychowania Fizycznego im. Eugeniusza Piaseckiego w Poznaniu

  26. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

  27. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  28. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Karolina Barbara Przepiórska-Drońska

    Instytut Farmakologii PAN

  29. A comprehensive approach to powders for pharmaceutical 3D printing using Selective Laser Sintering - development of stra...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr hab. Piotr Paweł Kulinowski

    Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie

  30. Establishing evidence-based strategic recommendations for patient-centred health care options for individuals experienci...

    Call: POLONEZ BIS 1 , Panel: NZ7

    Principal investigator: dr Iwona Anna Bielska

    Uniwersytet Jagielloński, Collegium Medicum

  31. Inhibition of protein disulfide isomerases as a strategy for reduction of prothrombotic state in atherosclerosis; therap...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Kamil Przyborowski

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  32. Non-provitamin A carotenoids as a novel therapeutic strategy in intestinal failure associated liver disease (IFALD)

    Call: PRELUDIUM BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Maciej Jan Stawny

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  33. New post-treatment strategy against stroke and perinatal asphyxia – a novel approach based on a selective activation of ...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Agnieszka Wnuk

    Instytut Farmakologii PAN

  34. Maternal obesity as a risk factor of autism spectrum disorder in offspring - in search of the role of the gut microbiota...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Dawid Mateusz Gawliński

    Instytut Farmakologii PAN

  35. Novel hope for diseased joints: a polymer-based treatment to promoteregenerative strategies for patients with osteoarthr...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marta Kędziora

    Instytut Farmakologii PAN

  36. Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodege...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii PAN

  37. Bioremediation of water pollution caused by drugs and cosmetics by Cunninghamella fungi - a biotechnological strategy fo...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr Karolina Anna Słoczyńska

    Uniwersytet Jagielloński, Collegium Medicum

  38. Towards innovative strategy for treatment of Alzheimer's Disease via dual inhibition of receptor 5-HT6 and kinase CDK5.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Sylwia Sudoł-Tałaj

    Uniwersytet Jagielloński, Collegium Medicum

  39. Insulin – metallacarborane conjugates: A new strategy to enhance the biological efficacy of peptide drugs

    Call: PRELUDIUM BIS 1 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Marek Goszczyński

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  40. Is recurring irrationality adaptively rational? The role of numeracy and adaptive strategy selection in decisions under ...

    Call: PRELUDIUM BIS 1 , Panel: HS6

    Principal investigator: dr hab. Jakub Traczyk

    Szkoła Wyższa Psychologii Społecznej w Warszawie

  41. Probabilistic forecasting as a tool for the optimization of decision processes in electricity markets

    Call: SONATA 15 , Panel: HS4

    Principal investigator: dr Joanna Barbara Janczura

    Politechnika Wrocławska

  42. Lipophilic Prodrug Charge Masking (LPCM) as a novel strategy to enhance oral bioavailability of charged active peptides....

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Agata Elżbieta Gitlin-Domagalska

    Uniwersytet Gdański, Wydział Chemii

  43. Neuroprotective properties of 5-HT6 receptor ligands in the group of 2-arylpyrrole derivatives – a new insight into neur...

    Call: PRELUDIUM 17 , Panel: NZ7

    Principal investigator: Marcin Józef Drop

    Uniwersytet Jagielloński, Collegium Medicum

  44. Searching for effective strategies to protect neuronal cells against hypoxia and ischemia: Identification of neuroprotec...

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

  45. Polycystic ovary syndrome in metabolomics. Is this the right strategy for explaining pathomechanism?

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: Anna Rajska

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  46. Inhibition of tyrosine phosphatase as a strategy to enhance insulin sensitivity through activation of chaperone mediated...

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: dr hab. Krzysztof Marycz

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Biologii i Hodowli Zwierząt

  47. Modifying motoneuron synaptic excitability with trans-spinal direct current stimulation (tsDCS) - A new method for amyot...

    Call: SONATA 13 , Panel: NZ7

    Principal investigator: dr Marcin Bączyk

    Akademia Wychowania Fizycznego im. Eugeniusza Piaseckiego w Poznaniu, Wydział Wychowania Fizycznego, Sportu i Rehabilitacji

  48. Modulation of inflammatory processes using new agonists of the formyl peptide receptors ALX/FPR2 as a new therapeutic st...

    Call: HARMONIA 9 , Panel: NZ7

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

  49. Individual and situational determinants of managerial risk in corporate governance of public companies in Poland

    Call: PRELUDIUM 13 , Panel: HS4

    Principal investigator: Amadeusz Jacek Miązek

    Uniwersytet Ekonomiczny w Poznaniu, Wydział Zarządzania

  50. Modulation mitochondrial metabolism and dynamics and tageting DNA methylation of adipose derived mesenchymal stromal ste...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Krzysztof Marycz

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Biologii i Hodowli Zwierząt

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy